38 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
four and 72 hours. According to the Global Burden of Disease Study conducted in 2019, migraine is the second leading disability in the world … , disability assessment, and physical function impact.
In October 2023, we announced topline results from our Phase 2 clinical trial of ABP-450
8-K
EX-10.13
8kt2p5
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-14.1
jy015t2n911e4i 44qp
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.2
1ce8x3vs7vthk
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.5
9aewoec
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.12
lxij7
27 Jul 23
Index to Financial Statements
5:28pm
8-K
e16wcfazz3p4kketfgmq
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.11
m6su207
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.1
uy8uf h1z0j
27 Jul 23
Index to Financial Statements
5:28pm